Results 321 to 330 of about 460,858 (405)

Tandem combination of ASCT and CAR T‐cell therapy in highly refractory CNS lymphomas

British Journal of Haematology, EarlyView.
Lydia Montes, Sylvain Choquet, Madalina Uzunov, Véronique Morel, Marine Baron, Damien Roos‐Weil, Magalie Joris, Caroline Delette, Delphine Lebon, Nabih Azar, Carole Metz, Lucia Nichelli, Magali Le Garff‐Tavernier, Clémentine Boccon‐Gibod, Claire Lacan, Laetitia Souchet, Khê Hoang‐Xuan, Carole Soussain, Inès Boussen, Caroline Houillier   +19 more
wiley   +1 more source

Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To describe the real‐world effects of trofinetide in individuals with Rett syndrome (RTT) using the 18‐month follow‐up analysis of the LOTUS study. Method Caregivers of any patients who were prescribed trofinetide under routine clinical care were eligible to participate.
Louise Cosand, Haya Mayman, Jenny Downs, Victor Abler   +3 more
wiley   +1 more source

Endoscopic ultrasound safety and efficacy in pediatric pancreatobiliary and gastrointestinal disorders: single-center retrospective trial. [PDF]

Front Pediatr
Zhang J, Deng Z.
europepmc   +1 more source

Clinical characteristics and outcomes of diabetes‐related ketoacidosis (DKA) in sodium‐glucose co‐transporter‐2 inhibitor (SGLT2i) users with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) offer significant cardiorenal benefits for people with type 2 diabetes (PwT2D). However, concerns remain regarding their association with diabetes‐related ketoacidosis (DKA). (1) To compare demographics, precipitating factors, biochemical features, management, and outcomes of acute DKA ...
Angelica Sharma, Shams Ali Baig, Rasiah Thayakaran, Lakshmi Rengarajan, Nevil C. Philip, Anu Ann Abraham, Aspasia Manta, Parth Narendran, Ketan Dhatariya, Guillermo E. Umpierrez, Punith Kempegowda, DEVI collaboration   +11 more
wiley   +1 more source

A case of acute pancreatitis caused by obstruction of the pancreatic duct with a plant-based broom bristle. [PDF]

Endoscopy
Chen T, Zhang S, Fan M, Wang A, Chen Y, Cheng X.   +5 more
europepmc   +1 more source

Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To determine the effectiveness and safety of early combination therapy with insulin degludec and intravenous insulin infusion (IVII) compared with IVII alone in diabetic ketoacidosis (DKA) management. Materials and methods This prospective, open‐label, randomised controlled trial included 80 adults (≥18 years) with DKA.
Kitti Thammakosol, Methus Jantarapootirat, Sirinapa Traiwanatham, Chutintorn Sriphrapradang   +3 more
wiley   +1 more source

Profound Hypoxemia in a Patient With Hypertriglyceridemia-Induced Pancreatitis. [PDF]

Fed Pract
Nguyen E, Xia J, Kim JS, Chang MR, Betancourt J, Jun D.   +5 more
europepmc   +1 more source

Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Population‐based studies have consistently shown that individuals with diabetes secondary to chronic pancreatitis (pancreatic diabetes) have a high risk of hypoglycaemia. We aimed to investigate whether this risk has declined over recent years following the introduction of modern glucose‐lowering medications. Materials and Methods In this
Line Davidsen, Morten H. Jensen, Asbjørn M. Drewes, Filip K. Knop, Frederico G. S. Toledo, Søren S. Olesen   +5 more
wiley   +1 more source

Progression of lipase activity and pancreatic lipase immunoreactivity in clinically healthy cats and cats with diet-responsive enteropathy. [PDF]

J Feline Med Surg
Moscoso Uribe F, Riond B, Del Chicca F, Ruetten M, Grimm F, Liesegang A, Kook PH.   +6 more
europepmc   +1 more source

Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This post hoc analysis assessed the efficacy and safety data in tirzepatide‐treated Korean patients with type 2 diabetes (T2D). Materials and Methods Data specifically from Korean patients treated with tirzepatide 5, 10, or 15 mg in the multicentre, randomised, open‐label, parallel‐group, phase 3 trials SURPASS‐AP‐Combo and SURPASS‐3 were
Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn   +11 more
wiley   +1 more source